Cosmos Holdings Inc
NASDAQ:COSM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cosmos Holdings Inc
Revenue
Cosmos Holdings Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cosmos Holdings Inc
NASDAQ:COSM
|
Revenue
$59.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Revenue
$244.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Revenue
$13.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Revenue
$6.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Mckesson Corp
NYSE:MCK
|
Revenue
$398B
|
CAGR 3-Years
13%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Cencora Inc
NYSE:COR
|
Revenue
$325.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Cosmos Holdings Inc
Glance View
Cosmos Holdings, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The company is headquartered in Chicago, Illinois. The company went IPO on 2010-05-19. The firm imports, exports and distributes pharmaceutical products of brand-name and generic pharmaceuticals, over-the-counter (OTC) medicines, and a variety of dietary and vitamin supplements through its distribution network. The firm operates its business through its subsidiaries: SkyPharm, Decahedron Ltd and Cosmofarm. SkyPharm is principally engaged in creating, developing and trading of its own branded nutraceutical products line, Sky Premium Life. Decahedron is engaged in trading branded and generic pharmaceutical products and medicines across the European Union (EU) member states. Cosmofarm is engaged in distribution of branded pharmaceutical products, OTC products, cosmetics, nursery, and dietary products to pharmacies across Greece. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, United Kingdom.
See Also
What is Cosmos Holdings Inc's Revenue?
Revenue
59.8m
USD
Based on the financial report for Sep 30, 2025, Cosmos Holdings Inc's Revenue amounts to 59.8m USD.
What is Cosmos Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
3%
Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Cosmos Holdings Inc have been 3% over the past three years , 3% over the past five years .
